冬季急性下呼吸道感染住院儿童病原学分析及临床流行病学特点

目的了解冬季儿童急性下呼吸道感染病原谱及临床流行病学特征,为临床抗感染及病原检测提供依据。方法对我院2006年12月～2007年2月急性下呼吸道感染住院患儿采用一次性无菌吸痰管经鼻腔插入7～8cm,达到咽部以下负压吸取1～2ml深部鼻咽分泌液送细菌培养,并对呼吸道合胞病毒(RSV),腺病毒(ADV),A、B型流感病毒(IFV),1、2及3型副流感病毒(PIV)等7种常见呼吸道病毒抗原进行检测及运用荧光定量聚合酶链反应(PCR)技术检测标本中支原体和衣原体DNA。结果①381份下呼吸道感染儿童痰标本中细菌培养阳性81份,病毒检测阳性133份,支原体和衣原体阳性分别12份与6份,混合感染标本44份,总标本病原学检出率为50.66%(193/381)。②RSV阳性标本112份,为最重要的感染病原,连续3个月RSV检出率均在30%左右,6月龄以下儿童占61.61%,2岁以下儿童占86.61%,阳性标本中78.57%的患儿有喘息表现。③大肠埃希菌(16株)、肺炎链球菌(14株)、肺炎克雷伯菌及金黄色葡萄球菌(各10株)、卡他莫拉菌布兰汉亚种(8株)、流感嗜血杆菌和副流感嗜血杆菌(各6株)表现为主要的致病菌。结论RSV感然仍为儿童冬季急性下呼吸道感染最主要的病原,尤其在2岁以下儿童,且易表现为喘息发作。仍有40%以上感染病原未明,儿童急性下呼吸道感染病原谱需进一步完善。     

2009～2010年上海地区急性呼吸道感染病毒病原谱分析

调查2009~2010年上海地区人群急性呼吸道感染(ARTI)的病毒性病原,探讨2009甲型H1N1流感暴发背景下呼吸道感染病毒病原谱的构成。采用套式多重反转录-聚合酶链反应(RT-PCR)和实时荧光定量RT-PCR方法,对来自2 044例患者的2 044份标本(包括2 005份鼻咽拭子和39份肺泡灌洗液),同时检测腺病毒(ADV)、副流感病毒(PIV)、甲型流感病毒(FluA)、乙型流感病毒(FluB)、微小核糖核酸病毒、呼吸道合胞病毒(RSV)、人偏肺病毒(hMPV)、冠状病毒(CoV)和人博卡病毒(HBoV)。其中,656(32.09%)份标本经呼吸道病毒检测为阳性,52份标本为双重感染。FluA检出率最高(13.36%),其后依次为微小核糖核酸病毒(10.23%)、FluB(4.84%)、ADV(1.96%)、PIV(1.76%)、RSV(1.32%)、CoV(0.59%)、hMPV(0.39%)和HBoV(0.20%)。但各月病毒检出率分布不均,2009和2010年呼吸道病毒检出率高峰出现在当年11月(53.07%和65.59%),低谷都出现在当年5月,且2009年5~9月的病毒检出率高于2010年同期(32.02%vs15.38%,P<0.05)。其中,2009甲型H1N1流感暴发导致2009年10月~2010年1月2009甲型H1N1流感病毒占当月检出FluA的100%,2009年6~9月也占当月检出FluA的较高比率,依次为90.91%(20/22)、75.00%(15/20)、48.00%(12/25)和56.25%(18/32)。比较甲型H3N2流感病毒和2009甲型H1N1流感病毒分别在上呼吸道感染(URTI)和下呼吸道感染(LRTI)中的检出率,无统计学差异(URTI,85.29%vs76.61%;LRTI,14.71%vs23.39%;P>0.05)。呼吸道病毒检出率还与年龄相关,0~4岁组和5~14岁组病毒检出率高于其他年龄组。在0~4岁及≥65岁组中,微小核糖核酸病毒检出率最高,FluA次之;其余年龄组中FluA检出率最高。混合感染中15岁以下儿童占50%(26/52),微小核糖核酸病毒与其他病毒混合感染占84.62%(44/52)。本研究表明,上海地区2009~2010年FluA是最常见的急性呼吸道感染病原,2009甲型H1N1流感病毒成为2009年FluA的优势亚型。微小核糖核酸病毒是混合感染中最常见的病原。结果提示,应长期监测主要呼吸道病毒的活动水平,并加强对微小核糖核酸病毒流行病学和致病性的研究。     

液相芯片MASA技术用于儿童呼吸道感染病原学研究

利用多靶点液相芯片(Multi-Analyte Suspension Array,MASA)技术对引起儿童呼吸道感染(respiratorytract infections,RTI)的病原,包括人类呼吸道合胞病毒A型和B型(Human respiratory syncytial virus A and B,RSVA、RSVB)、严重急性呼吸综合征冠状病毒(Severe acute respiratory syndrome coronavirus,SARS-CoV)、流行性感冒病毒A型和B型(Influenza A virus and Influenza B virus,INFa,INFb)、副流感病毒1型和3型(Parainfluenza virus 1 and 3,PIV1,PIV3)、衣原体(C.pneumoniae,CPN)和支原体(M.pneumomae,MPN)进行了病原学研究.我们采集并分析了140例患典型呼吸道感染症状儿童的咽拭子,发现在这些标本中至少被前述的一种病原感染的标本有95例,阳性率为67.86%.结果显示这些标本中上述病原感染的情况分别为RSVB感染的患儿占35.71%、PIV3感染的占4.29%、INFa感染的占28.57%、INFb感染的占2.14%、MPN感染的占3.57%、CPN感染的占17.86%,被两种以上病原混合感染的患儿有17.14%.这些标本中都没有检测到RSVA、PIV1和SARS-CoV病原的感染.RSVB病原的感染率在3岁以下的患儿中明显高于3岁以上的患儿,而INFa的感染情况则相反;在上呼吸道感染患儿中检测到INFa病原感染的比例明显高于下呼吸道感染,而RSVB病原感染的情况相反.此外,我们发现在2005年3月-5月中造成武汉地区儿童呼吸道感染的主要病原是以RSVB、INFa、CPN为主,而RSVB感染则又是引起儿童下呼吸道感染和引起低龄儿童呼吸道感染的重要病原.     

液相芯片MASA技术用于儿童呼吸道感染病原学研究

利用多靶点液相芯片(Multi-Analyte Suspension Array,MASA)技术对引起儿童呼吸道感染(respiratory tract infections,RTI)的病原,包括人类呼吸道合胞病毒A型和B型(Human respiratory syncytial virus A and B, RSVA、RSVB)、严重急性呼吸综合征冠状病毒(Severe acute respiratory syndrome coronavirus,SARS-CoV)、流行 性感冒病毒A型和B型(Influenza A virus and Influenza B virus,INFa,INFb)、副流感病毒1型和3型(Parain- fluenza virus 1 and 3,PIV1,PIV3)、衣原体(C．pneumoniae,CPN)和支原体(M．pneumoniae,MPN)进行了病原学 研究。我们采集并分析了140例患典型呼吸道感染症状儿童的咽拭子,发现在这些标本中至少被前述的一种病 原感染的标本有95例,阳性率为67．86％。结果显示这些标本中上述病原感染的情况分别为:RSVB感染的患儿 占35．71％、PIV3感染的占4．29％、INFa感染的占28．57％、INFb感染的占2．14％、MPN感染的占3．57％、CPN 感染的占17．86％,被两种以上病原混合感染的患儿有17．14％。这些标本中都没有检测到RSVA、PIV1和SARS- CoV病原的感染。RSVB病原的感染率在3岁以下的患儿中明显高于3岁以上的患儿,而INFa的感染情况则相 反;在上呼吸道感染患儿中检测到INFa病原感染的比例明显高于下呼吸道感染,而RSVB病原感染的情况相反。 此外,我们发现在2005年3月-5月中造成武汉地区儿童呼吸道感染的主要病原是以RSVB、INFa、CPN为主,而 RSVB感染则又是引起儿童下呼吸道感染和引起低龄儿童呼吸道感染的重要病原。     

石家庄市儿童呼吸道感染病原体IgM抗体结果分析

目的分析石家庄市儿童呼吸道感染病原体的流行特点,为临床预防和治疗呼吸道感染提供病原学依据。方法纳入就诊于儿科的呼吸道感染患儿936例,运用间接免疫荧光法检测儿童血清的八种呼吸道病原体的IgM型抗体。根据不同季节、不同年龄和不同性别分组,分析其病原体阳性率和感染类型。结果 936例患儿血清标本中,检出病原体IgM抗体共424例,阳性率为45.30%。其中肺炎支原体阳性率(28.63%)最高,其次依次为流感病毒B型、呼吸道合胞病毒、流感病毒A型、肺炎衣原体、腺病毒、副流感病毒,未检出嗜肺军团菌。不同季节病原体的阳性率有差异,冬季的病原体阳性率(50.33%)显著高于夏、秋季的阳性率(33.71%和41.46%),差异均有统计学意义;不同年龄组中,婴儿组病原体阳性率(16.05%)显著低于其他3个年龄组,差异均有统计学意义;检出病原体的424例阳性患儿中,单一病原体感染类型者为290例(30.98%),混合感染者134例(14.32%);全部936例患儿中,男童病原体阳性率(42.33%)显著低于女童阳性率(52.29%);病原体混合感染类型中以肺炎支原体和流感病毒B型混合感染最常见,其中婴儿组混合感染病原体检出率均显著低于幼儿组、学龄前组和学龄组。结论肺炎支原体全年在儿童呼吸道感染中占主要地位。年龄和性别是石家庄市儿童呼吸道病原体感染的特异性因素,冬季为呼吸道病原体感染高峰期。     

569例呼吸道感染住院儿童7种常见呼吸道病毒病原学分析

目的了解呼吸道感染住院患儿呼吸道病毒的分布情况。方法选取2015年7月至2016年6月呼吸道感染的住院患儿病例,抽取鼻咽分泌物,采用直接免疫荧光法检测常见的7种病毒,即呼吸道合胞病毒(RSV)、甲型流感病毒(IVA)、乙型流感病毒(IVB)、副流感病毒1型(PIV1)、副流感病毒2型(PIV2)、副流感病毒3型(PIV3)、腺病毒(IVD)。结果共有569例样本送检,193例病毒检测阳性(33.92%),其中有3例为2种病毒的混合感染。男性共369例,女性共200例。其中RSV、PIV3、ADV的感染率居前三位。呼吸道病毒的感染率随着患儿年龄的增长逐渐下降,除新生儿外,6个月内的婴幼儿呼吸道病毒检出率最高。RSV检测阳性率自11月开始呈增高趋势,12月最高,达55.86%。PIV3的检出高峰出现在7月,达13.64%。结论 RSV是本地区儿童呼吸道感染最常见的病毒。呼吸道病毒的检出率与年龄、季节等因素有关。     

347例SARI病例15种常见呼吸道病原特征分析

了解新疆维吾尔自治区人民医院住院严重急性呼吸道感染(Severe acute respiratory infection,SARI)病例呼吸道病原的构成及主要病原的流行规律,为SARI的防控提供线索和依据。应用多重PCR方法对2015年8月至2016年7月期间在新疆维吾尔自治区人民医院儿科、呼吸科、急诊科住院,且符合SARI病例定义的每周二、周四、周六新入院的患者进行检测。347份标本中检出14种呼吸道病原,未检测出衣原体,检出病毒阳性标本144份,阳性率为41.50%,检出前4位的病毒依次是,流感病毒72份、鼻病毒18份、呼吸道合胞病毒15份、偏肺病毒和副流感病毒各13份,阳性率分别为为20.75%,5.19%,4.32%,3.75%,3.75%,检出细菌阳性标本数为155份,阳性率为44.67%,其中肺炎链球菌阳性108份、流感嗜血杆菌阳性62份,肺炎支原体阳性13份,阳性率分别为31.12%、17.87%、3.75%;在108份肺炎链球菌阳性标本中41份标本合并病毒感染。新疆维吾尔自治区人民医院SARI病例病原主要以流感病毒,肺炎链球菌和流感嗜血杆菌为主,各年龄组均有检出,检出病原阳性高峰为冬春季;5岁及以下标本中检出腺病毒和百日咳杆菌会增加收住ICU的风险。     

昆明儿童呼吸道感染9种病原体IgM抗体检测结果分析

目的分析2016年1—12月1 136例门诊及住院拟诊呼吸道感染的4月龄～12岁患者,了解昆明地区儿童呼吸道感染患者中9种常见病原体(嗜肺军团菌、肺炎支原体、肺炎衣原体、Q热立克次体、腺病毒、呼吸道合胞病毒、甲型流感病毒、乙型流感病毒和副流感病毒)的感染情况。方法采用间接免疫荧光法,检测患儿的血清中9种病原体。通过SPSS统计软件比较分析阳性检测率在不同年龄、季节、性别患儿阳性病例数及阳性率的差异。结果1 136例儿童呼吸道感染患者中,IgM抗体检测阳性534例,阳性率为47%。9种病原体IgM抗体阳性率,MP阳性率最高(40.8%),COX最低(0.0%)。单一病原体感染487例,阳性率为42.9%,混合病原体感染47例,阳性率为4.1%。统计分析结果显示,各年龄组(婴儿组、幼儿组、学龄前期组、学龄期组),学龄期组IgM阳性率最高(54.1%),幼儿组最低(39.8%),组间差异有统计学意义(X~2=18.729、P0.05)。春、夏、秋、冬IgM阳性率分别是44.9%、53.5%、43.8%和45.5%,组间差异无统计学意义(X~2=6.657、P=0.084,P0.05)。患者男女性别IgM阳性率分别是37.8%和58.8%,组间差异有统计学意义(X~2=49.562、P0.05)。结论昆明地区儿童呼吸道感染以MP为主,学龄前期及学龄期儿童感染率较高,无季节差异,女性患儿多于男性。     

流感病毒感染诱导T细胞免疫应答的研究进展

A型流感病毒(Influenza A virus,IAV)属正粘病毒科流感病毒属,是造成人畜呼吸道感染的重要病原微生物。随着研究的不断深入,国内外不断发现肺脏效应CD4+T细胞、CD8+T细胞和调节性T细胞利用多重效应和调节机制控制IAV感染。本文通过查阅流感病毒介导T细胞免疫反应的有关文献,主要对IAV逃逸T细胞免疫的策略、宿主感染IAV过程中T细胞亚群和固有免疫样T细胞产生的免疫反应等方面展开综述,为国内相关领域的研究提供理论依据。     

闽南地区5 869例儿童社区获得性肺炎患者 病原学特点分析

目的通过对闽南地区社区获得性肺炎(CAP)患儿病原特点进行分析,为CAP早期预警、预防和早期经验治疗提供指导和依据。方法收集我院2015年1月至2017年5月5 869例CAP患儿静脉血、呼吸道分泌物及痰标本分别进行肺炎支原体(MP)、呼吸道病毒检测以及细菌培养和鉴定。结果 5 869例CAP患儿中明确病原体感染4 931例,其中单纯细菌感染3 054例,单纯病毒感染966例,单纯MP感染620例,混合感染291例,未检出病原体938例。细菌性病原主要以肺炎链球菌、流感嗜血杆菌和卡他莫拉菌为主,在各季节检出率不同且男性多于女性,主要在低龄儿童中检出。病毒感染者主要分布于低龄儿童,夏季检出率最高,病原以呼吸道合胞病毒(RSV)为主,占68.22%。该类患者在性别上比较差异无统计学意义。MP感染者中女性多于男性,主要分布于大龄儿童,冬季检出率最高。结论本地区CAP患儿病原检出率由高到低分别为细菌、病毒和MP。细菌和MP检出率在患儿中具有性别差异,各种病原在不同年龄段儿童及季节中检出率不同。     

Acute viral infections of upper respiratory tract in elderly people living in the community: comparative,prospective, population based study of disease burden.

OBJECTIVE: To evaluate the disease burden of upper respiratory infections in elderly people living at home. DESIGN: Prospective surveillance of elderly people. INTERVENTION: None. SETTING: Leicestershire, England SUBJECTS: 533 subjects 60 to 90 years of age. MAIN OUTCOME MEASURES: Pathogens, symptoms, restriction of activity, duration of illness, medical consultations, interval between onset of illness and medical consultation, antibiotic use, admission to hospital, and death. RESULTS: 231 pathogens were identified for 211 (43%) of 497 episodes for which diagnostic specimens were available: 121 (52%) were rhinoviruses, 59 (26%) were coronaviruses, 22 (9.5%) were influenza A or B, 17 (7%) were respiratory syncytial virus, 7 (3%) were parainfluenza viruses, and 3 (1%) were Chlamydia species; an adenovirus and Mycoplasma pneumoniae caused one infection each. Infections occurred at a rate of 1.2 episodes per person per annum (95% confidence interval 1.0 to 1.7; range 0-10) and were clinically indistinguishable. Lower respiratory tract symptoms complicated 65% of upper respiratory infections and increased the medical consultation rate 2.4-fold (chi 2 test P < 0.001). The median interval between onset of illness and medical consultation was 3 days for influenza and 5 days for other infections. Rhinoviruses caused the greatest disease burden overall followed by episodes of unknown aetiology, coronaviruses, influenza A and B, and respiratory syncytial virus. CONCLUSIONS: Respiratory viruses cause substantial morbidity in elderly people. Although respiratory syncytial virus and influenza cause considerable individual morbidity, the burden of disease from rhinovirus infections and infections of unknown aetiology seems greater overall. The interval between onset of illness and consultation together with diagnostic difficulties raises concern regarding the role of antiviral drugs in treating influenza.     

A、B、C三型流感病毒病毒学、流行病学、临床特征和流感疫苗

２０世纪人类遭受了４次流感大流行,数千万人失去了生命,流感病毒分Ａ、Ｂ、Ｃ三型,对其病毒学、流行病学和临床特征,以及流感病毒传统疫苗－－灭活疫苗和新型疫苗－－核酸疫苗的研究进展作了论述。     

Influenza A/H1N1 2009 Pandemic and Respiratory Virus Infections,Beijing, 2009–2010

To determine the role of the pandemic influenza A/H1N1 2009 (A/H1N1 2009pdm) in acute respiratory tract infections (ARTIs) and its impact on the epidemic of seasonal influenza viruses and other common respiratory viruses, nasal and throat swabs taken from 7,776 patients with suspected viral ARTIs from 2006 through 2010 in Beijing, China were screened by real-time PCR for influenza virus typing and subtyping and by multiplex or single PCR tests for other common respiratory viruses. We observed a distinctive dual peak pattern of influenza epidemic during the A/H1N1 2009pdm in Beijing, China, which was formed by the A/H1N1 2009pdm, and a subsequent influenza B epidemic in year 2009/2010. Our analysis also shows a small peak formed by a seasonal H3N2 epidemic prior to the A/H1N1 2009pdm peak. Parallel detection of multiple respiratory viruses shows that the epidemic of common respiratory viruses, except human rhinovirus, was delayed during the pandemic of the A/H1N1 2009pdm. The H1N1 2009pdm mainly caused upper respiratory tract infections in the sampled patients; patients infected with H1N1 2009pdm had a higher percentage of cough than those infected with seasonal influenza or other respiratory viruses. Our findings indicate that A/H1N1 2009pdm and other respiratory viruses except human rhinovirus could interfere with each other during their transmission between human beings. Understanding the mechanisms and effects of such interference is needed for effective control of future influenza epidemics.     

Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?

Historically, most research on infectious diseases has focused on infections with single pathogens. However, infections with pathogens often occur in the context of pre-existing viral and bacterial infections. Clinically, this is of particular relevance for coinfections with Streptococcus pneumoniae and influenza virus, which together are an important cause of global morbidity and mortality. In recent years new evidence has emerged regarding the underlying mechanisms of influenza virus-induced susceptibility to secondary pneumococcal infections, in particular regarding the sustained suppression of innate recognition of S. pneumoniae. Conversely, it is also increasingly being recognized that there is not a unidirectional effect of the virus on S. pneumoniae, but that asymptomatic pneumococcal carriage may also affect subsequent influenza virus infection and the clinical outcome. Here, we will review both aspects of pneumococcal influenza virus infection, with a particular focus on the age-related differences in pneumococcal colonization rates and invasive pneumococcal disease.     

Prevalence and structure of acute respiratory virus infections

Information on epidemiology of acute respiratory virus infections (ARVI) is reviewed and analyzed. In addition to influenza viruses, the role of respiratory syncytial viruses (RSV), rhino- and adenoviruses, as well as other viruses, in the development of respiratory diseases, especially in newborns, young children and elderly persons, is emphasized. A high proportion of RSV in the etiology the severe forms of ARVI and in the development of intrauterine infection is pointed out. The conclusion has been made that the identification of the causative agents of ARVI with the use of modern methods makes it possible to determine the real role of each of the pathogens in the formation of the severe forms of diseases, as well as the expediency of vaccinal prophylaxis.     

Coinfection of wild ducks by influenza A viruses: distribution patterns and biological significance.

Coinfection of wild birds by influenza A viruses is thought to be an important mechanism for the diversification of viral phenotypes by generation of reassortants. However, it is not known whether coinfection is a random event or follows discernible patterns with biological significance. In the present study, conducted with viruses collected throughout 15 years from a wild-duck population in Alberta, Canada, we identified three discrete distributions of coinfections. In about one-third of the events, which involved subtypes of viruses that appear to be maintained in this duck reservoir, coinfection occurred at rates either close to or significantly lower than one would predict from rates of single-virus infection. Apparently, the better adapted an influenza A virus is to an avian population, the greater is its ability to prevent coinfections. Conversely, poorly adapted, nonmaintained viruses were significantly overrepresented as coinfectants. Rarely encountered subtypes appear to represent viruses whose chances of successfully infiltrating avian reservoirs are increased by coinfection. Mallards (Anas platyrhynchos) and pintails (A. acuta) were significantly more likely to be infected by a single influenza A virus than were the other species sampled, but no species was significantly more likely to be coinfected. These observations provide the first evidence of nonrandom coinfection of wild birds by influenza A viruses, suggesting that reassortment of these viruses in a natural population does not occur randomly. These results suggest that even though infections may occur in a species, all subtypes are not maintained by all avian species. They also suggest that specific influenza A virus subtypes are differentially adapted to different avian hosts and that the fact that a particular subtype is isolated from a particular avian species does not mean that the virus is maintained by that species.     

Pathogenic mechanisms of invasive group A Streptococcus infections by influenza virus–group A Streptococcus superinfection

Group A Streptococcus (GAS) are pathogenic bacteria of the genus Streptococcus and cause severe invasive infections that comprise a wide range of diverse diseases, including acute respiratory distress syndrome, renal failure, toxic shock‐like syndrome, sepsis, cellulitis and necrotizing fasciitis. The essential virulence, infected host and external environmental factors required for invasive GAS infections have not yet been determined. Superinfection with influenza virus and GAS induced invasive GAS infections was demonstrated by our team in a mouse model, after which clinical cases of invasive GAS infections secondary to influenza virus infection were reported by other investigators in Japan, USA, Canada, UK China, and other countries. However, the pathogenic mechanisms underlying influenza virus‐GAS superinfection are not yet fully understood. The present review describes the current knowledge about invasive GAS infections by superinfection. Topics addressed include the bacteriological, virological and immunological mechanisms impacting invasion upon superinfection on top of underlying influenza virus infection by GAS and other bacteria (i.e., Streptococcus pneumoniae and Staphylococcus aureus). Future prospects are also discussed.

     

Long-Term Shedding of Influenza Virus,Parainfluenza Virus,Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders

Respiratory viruses are a cause of upper respiratory tract infections (URTI), but can be associated with severe lower respiratory tract infections (LRTI) in immunocompromised patients. The objective of this study was to investigate the genetic variability of influenza virus, parainfluenza virus and respiratory syncytial virus (RSV) and the duration of viral shedding in hematological patients. Nasopharyngeal swabs from hematological patients were screened for influenza, parainfluenza and RSV on admission as well as on development of respiratory symptoms. Consecutive swabs were collected until viral clearance. Out of 672 tested patients, a total of 111 patients (17%) were infected with one of the investigated viral agents: 40 with influenza, 13 with parainfluenza and 64 with RSV; six patients had influenza/RSV or parainfluenza/RSV co-infections. The majority of infected patients (n = 75/111) underwent stem cell transplantation (42 autologous, 48 allogeneic, 15 autologous and allogeneic). LRTI was observed in 48 patients, of whom 15 patients developed severe LRTI, and 13 patients with respiratory tract infection died. Phylogenetic analysis revealed a variety of influenza A(H1N1)pdm09, A(H3N2), influenza B, parainfluenza 3 and RSV A, B viruses. RSV A was detected in 54 patients, RSV B in ten patients. The newly emerging RSV A genotype ON1 predominated in the study cohort and was found in 48 (75%) of 64 RSV-infected patients. Furthermore, two distinct clusters were detected for RSV A genotype ON1, identical RSV G gene sequences in these patients are consistent with nosocomial transmission. Long-term viral shedding for more than 30 days was significantly associated with prior allogeneic transplantation (p = 0.01) and was most pronounced in patients with RSV infection (n = 16) with a median duration of viral shedding for 80 days (range 35–334 days). Long-term shedding of respiratory viruses might be a catalyzer of nosocomial transmission and must be considered for efficient infection control in immunocompromised patients.